AD:EURONEXT AMSTERDAMKoninklijke Ahold Delhaize N.V. Analysis
Data as of 2026-03-10 - not real-time
$49.06
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Array Digital Infrastructure is trading slightly above its discounted cash‑flow estimate, indicating modest upside potential, yet its price sits under both the short‑term and mid‑term moving averages, signaling a bearish technical backdrop. The RSI hovers around the neutral zone and the MACD histogram has turned positive, offering a hint of bullish momentum that could support a short‑term bounce. Recent earnings outperformed expectations, driven by a sizable spectrum asset sale to AT&T and a special dividend, but the company still faces steep revenue contraction, thin profit margins and negative free cash flow, which temper the optimism.
Given the mixed technical signals, high valuation relative to peers, and ongoing cash‑flow challenges, a cautious stance is warranted—maintain exposure in the near term while monitoring cash‑flow trends and debt servicing capacity for any longer‑term shift.
Given the mixed technical signals, high valuation relative to peers, and ongoing cash‑flow challenges, a cautious stance is warranted—maintain exposure in the near term while monitoring cash‑flow trends and debt servicing capacity for any longer‑term shift.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages suggests limited upside
- MACD histogram turning positive may enable a brief rebound
- Recent earnings beat and special dividend provide short‑term support
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue contraction and negative free cash flow raise sustainability concerns
- DCF valuation indicates modest upside but high PE relative to industry
- Debt level is manageable but requires careful monitoring
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistent revenue decline and thin profit margins threaten long‑term profitability
- Infrastructure assets are valuable but capital‑intensive with limited growth
- High valuation multiples and limited dividend policy reduce long‑term appeal
Key Metrics & Analysis
Financial Health
Revenue Growth-93.80%
Profit Margin0.43%
P/E Ratio25.3
ROE5.34%
ROA1.43%
Debt/Equity46.59
P/B Ratio1.7
Op. Cash Flow$524.4M
Free Cash Flow$-523754624
Industry P/E18.3
Technical Analysis
TrendBearish
RSI47.5
Support$46.82
Resistance$52.00
MA 20$49.31
MA 50$51.15
MA 200$55.45
MACDBullish
VolumeDecreasing
Fear & Greed Index76.09
Valuation
Fair Value$46.17
Target Price$53.83
Upside/Downside9.73%
GradeFair
TypeBlend
Risk Assessment
Beta0.50
Volatility24.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.